• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC201000
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Ruptured Aneurysm (4436)
Date of Event 04/10/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
According to the gore® excluder® aaa endoprosthesis featuring c3 deployment system instructions for use, potential adverse events that may occur include, but are not limited to, endoleak and aneurysm rupture.The ifu also advises that this treatment modality requires long-term, regular follow-up to assess the patients¿ health status and stent-graft performance.Patients with specific clinical findings (e.G., endoleak, enlarging aneurysms) should receive enhanced follow-up.
 
Event or Problem Description
On (b)(6) 2021, this patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprosthesis featuring c3 deployment system.On (b)(6) 2022, the patient presented to the hospital with a stable ruptured abdominal aortic aneurysm.On computed tomography, contrast was seen in the aneurysm sac and in the right iliac artery.The physician believes the patient may have had an undiagnosed endoleak.On (b)(6) 2022, a reintervention was performed whereby a gore® excluder® aortic extender endoprosthesis (pla320400) was placed proximally, and a gore® excluder® contralateral leg endoprosthesis (plc201200) was placed in the right iliac artery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
douglas rhodes
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14288969
Report Number3013164176-2022-01365
Device Sequence Number5524628
Product Code MIH
UDI-Device Identifier00733132618590
UDI-Public00733132618590
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/16/2022
Device Model NumberPLC201000
Device Catalogue NumberPLC201000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/10/2022
Initial Report FDA Received Date05/05/2022
Date Device Manufactured12/17/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
RLT281414/(B)(4)
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age56 YR
Patient SexMale
-
-